|
|
||||||||
Resistance to antifolate antimalarial drugs (cycloguanil, a biologically active metabolite of proguanil, and pyrimethamine) is associated with a Ser- to Asn-108 point mutation in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. The frequency of this mutation was studied in 127 clinical isolates obtained in Yaounde, Cameroon using a simple and rapid molecular technique based on the polymerase chain reaction and restriction fragment length polymorphism. Of the 127 isolates, pure wild-type Ser-108 codon, pure mutant-type Asn-108 codon, and mixed codons were observed in 66, 55, and six parasites, respectively. The proportion of antifolate-resistant, pure mutant-type codon, with respect to pure wild-type or mixed alleles, was 43% (55 of 127). The results of the molecular assay were compared with those of semimicro isotopic in vitro assay in 34 isolates. All 17 pure Ser-108 isolates and two isolates with mixed alleles were sensitive to both pyrimethamine (50% inhibitory concentration [IC50] < 100 nM) and cycloguanil (IC50 < 50 nM). Fourteen of 15 isolates with the mutant-type Asn-108 codon were resistant to pyrimethamine and cycloguanil. One isolate with Asn-108 showed a slightly elevated pyrimethamine IC50 (78 nM), which was within the sensitive range. This study provides further evidence that antifolate-resistant P. falciparum isolates are already present in Yaounde, Cameroon.
This article has been cited by other articles:
![]() |
R. Tahar and L. K. Basco Molecular Epidemiology of Malaria in Cameroon. XXVI. Twelve-Year In Vitro and Molecular Surveillance of Pyrimethamine Resistance and Experimental Studies to Modulate Pyrimethamine Resistance Am J Trop Med Hyg, August 1, 2007; 77(2): 221 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. TINTO, J. B. OUEDRAOGO, I. ZONGO, C. VAN OVERMEIR, E. VAN MARCK, T. R. GUIGUEMDE, and U. D'ALESSANDRO SULFADOXINE-PYRIMETHAMINE EFFICACY AND SELECTION OF PLASMODIUM FALCIPARUM DHFR MUTATIONS IN BURKINA FASO BEFORE ITS INTRODUCTION AS INTERMITTENT PREVENTIVE TREATMENT FOR PREGNANT WOMEN Am J Trop Med Hyg, April 1, 2007; 76(4): 608 - 613. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lau, J. T. Ferlan, V. H. Brophy, A. Rosowsky, and C. H. Sibley Efficacies of Lipophilic Inhibitors of Dihydrofolate Reductase against Parasitic Protozoa Antimicrob. Agents Chemother., January 1, 2001; 45(1): 187 - 195. [Abstract] [Full Text] |
||||
![]() |
J. F. J. Kun, L. G. Lehman, B. Lell, R. Schmidt-Ott, and P. G. Kremsner Low-Dose Treatment with Sulfadoxine-Pyrimethamine Combinations Selects for Drug-Resistant Plasmodium falciparum Strains Antimicrob. Agents Chemother., September 1, 1999; 43(9): 2205 - 2208. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |